本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ovid Therapeutics Inc.

0.5500
+0.070714.75%
盘后0.56000.0100+1.82%19:58 EDT
成交量:346.80万
成交额:181.84万
市值:3,911.02万
市盈率:-1.60
高:0.5700
开:0.5300
低:0.4800
收:0.4793
数据加载中...
2023/05/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

重要事件披露

8-K - Current report
2023/05/01

重要事件披露

8-K - Current report
2023/04/27

重要事件披露

8-K - Current report
2023/03/13

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]